近5年国外胰腺癌放化疗研究热点和合著网络分析  

Hot spots and co-authorship in foreign studies on pancreatic cancer radio chemotherapy in recent 5 years

作　　者：郑伟[1] 康静波[1] 温居一[1] 张新红[1] 王静[1] 

机构地区：[1]中国人民解放军海军总医院,北京100048

出　　处：《中华医学图书情报杂志》2016年第7期37-43,共7页Chinese Journal of Medical Library and Information Science

摘　　要：目的:分析国外近5年来胰腺癌放化疗研究的相关文献,获得研究热点及发展态势、高产作者团体及机构等信息。方法:下载Pub Med数据库中相关文献,经BICOMB软件提取后,对高频主题词和论文进行文献计量学双聚类分析和战略坐标分析,并对高产作者进行合著类团分析。结果:现今国外胰腺癌放化疗研究主要分为胰腺导管腺癌放化疗前后病理学特征研究、结合胰腺癌的遗传代谢方面和抗肿瘤药的药理学方面探究胰腺癌的药物疗法、外科学结合放射疗法及化学药物等新型综合疗法治疗胰腺癌等6个热点领域,高产作者可大致划分为来自日本和美国的两个大团体和若干小团体。结论:对于成熟的研究主题应该从中寻找新的突破点,对于有进一步发展空间的主题应给予更多的关注,高产作者类团分析提示我们在研究中应加强团体合作。Objective To collect the hot spots,development trends,high yield authors and their affiliated institutions by analyzing the papers on pancreatic cancer chemotherapy in recent 5 years. Methods The papers on pancreatic cancer chemotherapy were downloaded from Pub Med. Their high frequency subject headings extracted by BICOMB were analyzed by bibliometric double clustering analysis and strategic coordinate analysis. The high yield authors were analyzed by co-authorship group analysis. Results The current studies on pancreatic cancer chemotherapy in foreign countries were focused on the pathological features of pancreatic duct adenocarcinoma before and after chemotherapy,drug therapy of pancreatic cancer according to its genetics,metabolism and pharmacology of antitumor drugs,surgical treatment combined with radiotherapy and chemotherapy for pancreatic cancer. The high yield authors could be divided into two large groups from Japan and USA and a number of small groups. Conclusion New breakthrough points should be found from the matured topics,the topics with a further developmental space should be greatly concerned,and cooperation should be strengthened between study groups or teams.

关 键 词：胰腺癌 放疗 化疗 文献计量学 网络分析 

分 类 号：G250.252[文化科学—图书馆学] R730.53[医药卫生—肿瘤]